The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
Open Access
- 19 January 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (2) , 202
Abstract
Maternal antibodies are passively transferred to the fetus via the placenta during gestation and can play an important role in protecting the newborn from infection. For example, in malaria-endemic regions, maternal antibodies likely provide substantial protection against Plasmodium falciparum malaria in the first 6 months of life. However, circulating maternal antibodies can also interfere with vaccine efficacy. Here, we used a mouse maternal transfer model to evaluate whether maternal antibodies interfere with the responsiveness to a virus-like particle (VLP)-based vaccine targeting the CIS43 epitope of the malaria circumsporozoite protein (CSP). We found immunized dams passively transfer to pups high levels of anti-CSP IgG antibodies that steadily decline as the animals age. We also found that the neonatal offspring of immunized mice do not respond to de novo immunization with the CIS43-targeted VLP vaccine until maternal antibody titers decline below an inhibitory threshold. These findings may have important implications for delineating the delicate balance between protection conferred by maternal antibodies and the offspring’s ability to respond to immunization.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 AI169739, T32 AI007538)
- National Institute of Allergy and Infectious Diseases (R01 AI169739, T32 AI007538)
This publication has 41 references indexed in Scilit:
- Importance of Timing of Maternal Combined Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Immunization and Protection of Young InfantsClinical Infectious Diseases, 2012
- Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 yearsVaccine, 2012
- Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their InfantsClinical Infectious Diseases, 2010
- Congenital and neonatal malaria in a rural Kenyan district hospital: An eight-year analysisMalaria Journal, 2010
- Effectiveness of Maternal Influenza Immunization in Mothers and InfantsNew England Journal of Medicine, 2008
- High Titers of Circulating Maternal Antibodies Suppress Effector and Memory B-Cell Responses Induced by an Attenuated Rotavirus Priming and Rotavirus-Like Particle-Immunostimulating Complex Boosting Vaccine RegimenClinical and Vaccine Immunology, 2006
- Lack of Association between Maternal Antibody and Protection of African Infants from Malaria InfectionInfection and Immunity, 2000
- Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in miceEuropean Journal of Immunology, 1998
- Risk of Severe Malaria among African Infants: Direct Evidence of Clinical Protection during Early InfancyThe Journal of Infectious Diseases, 1998
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977